Horizon Pharma Public Limited Company (HZNP)
(Delayed Data from NSDQ)
$26.54 USD
+0.55 (2.12%)
Updated May 3, 2019 04:00 PM ET
After-Market: $26.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For HZNP
-
Horizon Therapeutics (HZNP) Up 10.4% Since Last Earnings Report: Can It Continue?
-
Horizon (HZNP) Q2 Earnings Top, Krystexxa & Uplizna Boost Sales
-
Horizon Therapeutics (HZNP) Surpasses Q2 Earnings and Revenue Estimates
-
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
-
Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?
-
Horizon (HZNP) Q1 Earnings and Revenues Miss Estimates
-
Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Lag Estimates
-
Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results
-
Horizon Therapeutics (HZNP) Down 0.9% Since Last Earnings Report: Can It Rebound?
-
Horizon's (HZNP) Q4 Earnings and Revenues Surpass Estimates
-
Horizon Therapeutics (HZNP) Q4 Earnings and Revenues Top Estimates
-
Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2022 Financial Results
-
Why Is Horizon Therapeutics (HZNP) Up 38.3% Since Last Earnings Report?
-
Horizon's (HZNP) Q3 Earnings & Revenues Surpass Estimates
-
Horizon Therapeutics (HZNP) Q3 Earnings and Revenues Beat Estimates
-
Horizon Therapeutics plc Reports Third-Quarter 2022 Financial Results; Increases Full-Year 2022 Net Sales and Adjusted EBITDA Guidance; Increases TEPEZZA and KRYSTEXXA Peak Annual Net Sales Expectations
-
Analysts Estimate Horizon Therapeutics (HZNP) to Report a Decline in Earnings: What to Look Out for
-
Horizon Therapeutics (HZNP) Down 9.2% Since Last Earnings Report: Can It Rebound?
-
Horizon (HZNP) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
-
Horizon Therapeutics (HZNP) Q2 Earnings and Revenues Lag Estimates
-
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
-
Analysts Estimate Horizon Therapeutics (HZNP) to Report a Decline in Earnings: What to Look Out for
-
Horizon (HZNP) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
-
Horizon Therapeutics (HZNP) Q1 Earnings and Revenues Beat Estimates
-
Horizon Therapeutics (HZNP) Earnings Expected to Grow: Should You Buy?